Celularity Inc - *W EXP 07/16/202 (CELUW)

CUSIP: 151190113

Q2 2026 13F Holders as of 30 Jun 2026

Share change
+99,729
SEC-reported price per share
$0.00
Number of holders
14
Value change
+$445
Number of buys
3
Number of sells
4

Security key

151190113

Report period

Q2 2026

Institutions

14

Top holders

10

Ownership snapshot

Top reported holders of CELUW - Celularity Inc - *W EXP 07/16/202 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Dragasac Ltd
Disclosed value leader
Dragasac Ltd
Comparable rows
3/15
Latest evidence
20 Apr 2026
13D/G 3/4/5 13F Lead comparable stake: 41% 12 rows are not safely comparable across share classes. 13D/G row: Dragasac Ltd Showing 1-6 of 15 holder rows.

Quick read

Dragasac Ltd leads the comparable SEC ownership view at 41%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Dragasac Ltd's linked filing trail.
Comparable ownership Top 3
Dragasac Ltd 41%
Philip & Daniele Barach Family Trust 20%
BRISTOL MYERS SQUIBB CO 1.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Dragasac Ltd
13D/G 3/4/5
Lim Kok Thay · 10%+ Owner
41%
Reported 13D/G · 24 Jul 2025
$27,710,796
14,138,161 shares
+$8,232,000 24 Jul 2025
Philip & Daniele Barach Family Trust
13D/G
20%
Reported 13D/G · 20 Apr 2026
—
7,558,665 shares
$0 20 Apr 2026
BRISTOL MYERS SQUIBB CO
13D/G
1.9%
Reported 13D/G · 31 Dec 2024
$174,813
426,372 shares
$0 31 Dec 2024
Lim Kok Thay
3/4/5
10%+ Owner
—
mixed-class rows
$13,119,993
10,538,161 shares
mixed-class rows
— 24 Jul 2025
STARR INTERNATIONAL CO INC
3/4/5
10%+ Owner
—
denominator unverified
$3,805,066
15,281,389 shares
— 01 Mar 2022
Sorrento Therapeutics, Inc.
3/4/5
10%+ Owner
—
denominator unverified
$1,257,556
5,050,427 shares
— 29 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
2,462,323
Rows available
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
14
Q2 2026 holders
14
Holder diff
0
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .